ACT 2 Logo
Peptide Therapy

Peptide Therapy · Weight-Loss Seekers

Peptides for Weight Loss

Here's something most people don't realize: some of the most effective weight-management medications available today are peptides. GLP-1 receptor agonists like semaglutide and tirzepatide are peptide-based — and for eligible patients, they've changed what's possible in medical weight management.

The key is using them well: as part of a structured plan that protects muscle and is monitored over time, not a shortcut handed over and forgotten.

We measure first. Then we act.

The context

Why weight resists after 45

Metabolism slows, muscle is harder to hold, hormones shift, and insulin sensitivity tends to drop. The strategies that worked at 30 quietly stop working — not for lack of effort, but because the underlying biology changed. The good news: these are measurable systems, and a plan can be built around the body you actually have.
How it may help

How GLP-1 peptides work

For eligible patients · Results vary
  • 01

    Appetite & blood sugar

    GLP-1 receptor agonists work with your body's own appetite and blood-sugar signaling to reduce hunger and support fat loss.

  • 02

    Semaglutide

    A GLP-1 receptor agonist that can help support appetite regulation and weight loss as part of a broader plan.

  • 03

    Tirzepatide

    Acts on two pathways (GLP-1 and GIP). In head-to-head studies it has shown greater average weight loss than semaglutide for many patients.

  • 04

    Tools, not shortcuts

    Best paired with adequate protein, strength training to protect muscle, and oversight for side effects — mostly mild GI, eased with careful titration.

Protecting muscle while you lose fat. Losing weight in midlife without losing muscle is the whole game. Our protocols emphasize protein, resistance training, and biomarker tracking so the weight you lose is fat — not the strength you'll need for the next thirty years.

Low noise. High signal.

An honest word on the evidence

GLP-1 receptor agonists are among the better-studied peptides in this space, but they're still tools that demand oversight — dosing, side-effect management, and muscle protection all matter. We keep it clinician-led, with honest expectations and monitoring on a regular cadence.
The bigger picture

Part of a complete metabolic plan

GLP-1 therapy sits inside our broader medical weight loss program, and weight resistance is sometimes a hormone story too — see hormone optimization. We treat the system, not a single number.
See the full approach
Questions

Frequently asked questions

  • Yes. GLP-1 receptor agonists like semaglutide and tirzepatide are peptide-based medications. For eligible patients we offer them as part of a structured, monitored plan.

  • Some muscle loss can occur with any significant weight loss. Our protocols are built to protect lean mass through protein, resistance training, and ongoing monitoring.

  • It's individual. Tirzepatide has shown greater average weight loss in studies, but the right choice depends on your biomarkers, history, and how you respond. A clinician decides with you.

  • Not necessarily. Your protocol is reviewed and adjusted over time; some members taper as habits and biomarkers improve. It's decided together, based on your data.

  • Results vary, and sustainable change is the goal. We track progress on a regular cadence rather than chasing a fast number.

Own your next chapter

Ready to make measurable progress?

Effective, monitored, muscle-protecting weight management is within reach for eligible patients. Start by measuring.

We measure first. Then we act.

ACT 2 Health provides clinician-led care. Treatments described are available only to eligible patients following clinical evaluation and within applicable regulations. This page is educational and is not medical advice. Individual results vary.